GNA Biosolutions is a private molecular diagnostics company. Founded by Federico Bursgens, Joachim Stehr, and Lars Ullerich in 2010, GNA Biosolutions is backed by investors that include btov Partners, KfW, Robert Bosch Venture Capital, SHS Gesellschaft fur Beteiligungsmanagement, and Unternehmertum Venture Capital Partners and is headquartered in Munich.